ADAMTS-7 expression increases in the early stage of angiotensin II-induced renal injury in elderly mice

Kidney and Blood Pressure Research

Volumn 38, Issue 1, 2014, Pages 121-131

  Gao, Yan Xiang ^a   Yu, Chang An ^b   Lu, Jian Hua ^a   Gao, Hong Mei ^a   Li, Geng ^b   Kong, Wei ^c   Zheng, Jingang ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b Institute of Clinical Medical Sciences   (China)

^c Neuroscience Research Institute   (China)

Author keywords

ADAMTS 7; Angiotensin II; Early stage; Elderly; Inflammatory; Renal injury

Indexed keywords

ADAMTS1 PROTEIN; ADAMTS7 PROTEIN; AGGRECANASE 1; ALBUMIN; ANGIOTENSIN II; CD68 ANTIGEN; GELATINASE B; LEUKOCYTE ELASTASE; MESSENGER RNA; METALLOPROTEINASE; NORADRENALIN; UNCLASSIFIED DRUG; ADAMTS 7 PROTEIN; CELL MARKER; EOSIN; HEMATOXYLIN; ADAM PROTEIN; ADAMTS7 PROTEIN, MOUSE; VASOCONSTRICTOR AGENT;

ADULT; AGED; AGING; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL INFILTRATION; CELL STRAIN HEK293; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; EARLY DIAGNOSIS; ELEVATED BLOOD PRESSURE; HISTOLOGY; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY CORTEX; KIDNEY INJURY; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; FEMALE; STAINING; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; C57BL MOUSE; CHEMICALLY INDUCED; GENETICS; HEK293 CELL LINE; INFLAMMATION; KIDNEY DISEASE; METABOLISM; PHYSIOLOGY;

ADAM PROTEINS; AGING; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; HEK293 CELLS; HUMANS; INFLAMMATION; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; VASOCONSTRICTOR AGENTS;

EID: 84895931391     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355758     Document Type: Article

References (26)

1. Campbell KH, O'Hare AM: Kidney disease in the elderly: update on recent literature. Curr Opin Nephrol Hypertens 2008;17:298-303.
2. O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC: Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006;17:846-853.
3. Davies I, Fotheringham AP, Faragher BE: Age-Associated changes in the kidney of the laboratory mouse. Age Ageing 1989;18:127-133.
4. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
5. Izquierdo MC, Perez-Gomez MV, Sanchez-Nino MD, Sanz AB, Ruiz-Andres O, Poveda J, Moreno JA, Egido J, Ortiz A: Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 2012;27 Suppl 4:iv6-10.
6. Excerpts from United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999;34:S1- 176.
7. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006;21:16-20.
8. Lavoz C, Rodrigues-Diez R, Benito-Martin A, Rayego-Mateos S, Rodrigues-Diez RR, Alique M, Ortiz A, Mezzano S, Egido J, Ruiz-Ortega M: Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One 2012;7:e40490.
9. Solini A, Rossi C, Santini E, Madec S, Salvati A, Ferrannini E: Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. J Hypertens 2011;29:1930-1939.
10. Whiting C, Castillo A, Haque MZ, Majid DS: Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney. Am J Physiol Renal Physiol 2013;305:F1031-F1041.
11. Wolf G: Renal injury due to renin-Angiotensin-Aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 2006;70:1914-1919.
12. Tao H, Rui C, Zheng J, Tang J, Wu L, Shi A, Chen N, He R, Wu C, Li J, Yin X, Zhang P, Zhu Z, Tao J, Xiao J, Mao C, Xu Z: Angiotensin II-mediated vascular changes in aged offspring rats exposed to perinatal nicotine. Peptides 2013;44:111-119.
13. Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarstrom A, Behrendt M, Andersson JO, Lindgren K, Andersson AK, Wallbrandt P, Rosengren B, Brodin P, Thelin A, Westin A, Hurt-Camejo E, Lee- Sogaard CH: Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 2005;25:180-185.
14. Wagsater D, Bjork H, Zhu C, Bjorkegren J, Valen G, Hamsten A, Eriksson P: ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 2008;196:514-522.
15. Wang L, Zheng J, Bai X, Liu B, Liu CJ, Xu Q, Zhu Y, Wang N, Kong W, Wang X: ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 2009;104:688-698.
16. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A, 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR: An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 2009;119:3637-3651.
17. Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH: NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 2007;50:189-196.
18. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin IImediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-1923.
19. Koletsky S, Rivera-Velez JM, Pritchard WH: Production of hypertension and vascular disease by angiotensin. Arch Pathol 1966;82:99-106.
20. Friese RS, Rao F, Khandrika S, Thomas B, Ziegler MG, Schmid-Schonbein GW, O'Connor DT: Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens 2009;31:521-533.
21. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH: Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006;20:1898-1900.
22. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K: Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272:556-562.
23. Salter RC, Ashlin TG, Kwan AP, Ramji DP: ADAMTS proteases: key roles in atherosclerosis? J Mol Med (Berl) 2010;88:1203-1211.
24. Pu X, Xiao Q, Kiechl S, Chan K, Ng FL, Gor S, Poston RN, Fang C, Patel A, Senver EC, Shaw-Hawkins S, Willeit J, Liu C, Zhu J, Tucker AT, Xu Q, Caulfield MJ, Ye S: ADAMTS7 Cleavage and Vascular Smooth Muscle Cell Migration Is Affected by a Coronary-Artery-Disease-Associated Variant. Am J Hum Genet 2013;92:366-374.
25. Maouche S, Schunkert H: Strategies beyond genome-wide association studies for atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:170-181.
26. Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y, Wang X, Xu M, Luo GZ, Zhu Y, Xu Q, Wang X, Kong W: Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 2012;32:2580-2588.